(Reuters) - Cipla Ltd, India's third-largest drugmaker by market capitalisation, posted on Wednesday a more than 10 percent rise in its first-quarter profit, well above analysts' expectations.
Net profit came in at 4.51 billion rupees ($65.67 million) in the three months ended June 30, compared with 4.09 billion rupees a year ago, the company said in a statement https://www.bseindia.com/xml-data/corpfiling/AttachLive/cd22e4bc-c6ea-4b53-b09b-2bfff73549e9.pdf.
Analysts on average had expected a profit of 3.91 billion rupees, Thomson Reuters Eikon data showed.
Net sales jumped 12 percent to 38.46 billion rupees.
($1 = 68.6725 Indian rupees)
Also Read
(Reporting by Krishna V Kurup in Bengaluru, Editing by Sherry Jacob-Phillips)
Disclaimer: No Business Standard Journalist was involved in creation of this content